Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunolo... Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. Mehr anzeigen
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland PR Newswire LONDON, Oct. 23, 2024 LONDON, Oct. 23, 2024...
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. PR Newswire LONDON...
Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference PR Newswire LONDON, Sept. 9, 2024 LONDON, Sept. 9, 2024 /PRNewswire/ -- Virax Biolabs ("Virax" or the...
Virax Biolabs to Participate at 7th European Congress of Immunology PR Newswire LONDON, Aug. 29, 2024 LONDON, Aug. 29, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company...
Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East PR Newswire LONDON, Aug. 28, 2024 LONDON, Aug...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.14 | 7.52688172043 | 1.86 | 2.079 | 1.76 | 240343 | 1.88395255 | CS |
| 4 | -0.55 | -21.568627451 | 2.55 | 2.55 | 1.76 | 299133 | 2.11697846 | CS |
| 12 | -3.23 | -61.759082218 | 5.23 | 5.52 | 1.46 | 2325286 | 2.61494684 | CS |
| 26 | 1.17 | 140.963855422 | 0.83 | 8.9999 | 0.75 | 3821692 | 3.78723667 | CS |
| 52 | -0.485 | -19.5171026157 | 2.485 | 8.9999 | 0.6 | 1987738 | 3.72010982 | CS |
| 156 | -198 | -99 | 200 | 290 | 0.6 | 1576137 | 22.0917488 | CS |
| 260 | -198 | -99 | 200 | 290 | 0.6 | 1576137 | 22.0917488 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
